Sandbox 77: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
<ref>Wiebke J, Schymura Y, Novoyatleva T, Kojonazarov B, Boehm M, Wietelmann A, Luitel H, Murmann K, Krompiec DR, Tretyn A, Pullamsetti SS, Weissmann N, Seeger W, Ghofrani HA, Schermuly RT. "5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312574] | <ref>Wiebke J, Schymura Y, Novoyatleva T, Kojonazarov B, Boehm M, Wietelmann A, Luitel H, Murmann K, Krompiec DR, Tretyn A, Pullamsetti SS, Weissmann N, Seeger W, Ghofrani HA, Schermuly RT. "5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure.” [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312574] | ||
<ref>Thompson AJ, Lummis SCR. " | <ref>Thompson AJ, Lummis SCR. "HT3 Receptors.” [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664614/] | ||
== References == | == References == | ||
<references /> | <references /> | ||
